Early Gastric Cancer, Endoscopic Submucosal Dissection, Historical Control Group, Multi-center, Single-arm Clinical Trial, Quality of Life and Cost Analysis
Conditions
Brief summary
The purpose of this study is to evaluate the safety and clinical effectiveness of ESD(Endoscopic Submucosal Dissection) for early gastric cancer analyzing short-term and long-term results of endoscopic treatment.
Detailed description
Traditionally open-gastrectomy is the standard treatment for gastric cancer without distant metastasis, but high mortality and morbidity, the intense weight loss, food intake difficulties after surgery are fraught, including problems with the drawback of significantly degrading the quality of life. Therefore, a lot of effort to seek the more simple treatment than open gastrectomy has been made, recently the endoscopic treatment for early gastric cancer is the most widely used treatment. This single-arm, multi-center study enroll early gastric cancer patients after ESD compared with the retrospective control(surgical treatment) group considering the unreality of the randomized clinical trials. In addition, the quality of life assessment by the EORTC C30/STO22 tools before and after ESD procedure in enrolled patients will be performed and the direct cost analysis also will be conducted.
Interventions
PROCEDUREEndoscopic Submucosal Dissection
5-years follow-up after Endoscopic Submucosal Dissection
Sponsors
National Evidence-Based Healthcare Collaborating Agency
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. ESD GROUP Inclusion Criteria: * Korean people aged \>=20 years * Endoscopic Grossly the lesion diameter ≤ 3cm * Endoscopic biopsy results: Well-differentiated and moderately differentiated adenocarcinoma * No ulcers in lesions * Endoscopic biopsy results: In case of gastric cancer, no metastasis in CT test performed before ESD procedure
Exclusion criteria
* Subject with history of malignant disease in other organs * Subject with history of stomach surgery due to peptic ulceration etc. * As the cases of an absolute contraindication of general anesthesia; Subject with chronic liver disease over Child score B, Subject with chronic Renal Disease requiring hemodialysis or peritoneal dialysis, Subject with heart failure more than Ⅲ score according to New York Heart Association Classification, Subject with severe systemic diseases such as respiratory disease * Subject with Bleeding tendency * Pregnant woman or woman with possibility of pregnancy * Subject who cann't be obtained informed consent * Subject who is unable to follow up for any other reason 2. Surgery Group(Retrospective data collection) Inclusion Criteria: * Subject with gastric laparoscopy or open-surgery for treatment early gastric cancer during 2002.1.1 \ 2004. 12. 31 * Korean people aged \>=20 years * Early gastric cancer confirmed by pathology during gastric surgery; Gastric cancer confirmed to the mucosal or submucosal regardless of lymph node metastasis * No history of malignant disease in other organs * No history of stomach surgery due to peptic ulceration etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 5-year disease(gastric cancer)-free survival rate after ESD procedure | 5 years after ESD |
Secondary
| Measure | Time frame |
|---|---|
| Short-term result(Histological complete resection,complication) | within the first 7 days after ESD |
| The incidence of reoccurrence and Ectopic foci | within the first 7 days and 3months, 6months, 1year, 2years, 3years, 4years and 5years after ESD |
| The quality of life after ESD | before and 7 days, 3months, 6months after ESD |
| The costs of ESD | From the admission to discharge |
| The safety of ESD procedure | within the 7 days, 3months, 6months, 1year, 2years, 3years, 4years and 5years after ESD |
Countries
South Korea
Contacts
Primary ContactEunhee Shin, Ph.D.
Backup ContactJonghee Kim, MS
Outcome results
None listed